GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

被引：0
|
作者：
Cryer, Byron [1 ]
Li, Chunming [2 ]
Simon, Lee S. [3 ]
Singh, Gurkirpal [4 ]
Stillman, Martin J. [5 ]
Berger, Manuela [2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Pfizer Inc, New York, NY USA
[3] SDG LLC, Cambridge, MA USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
[5] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
来源：
ARTHRITIS RESEARCH & THERAPY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P63
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial Clinical article
    Senbokuya, Nobuo
    Kinouchi, Hiroyuki
    Kanemaru, Kazuya
    Ohashi, Yasuhiro
    Fukamachi, Akira
    Yagi, Shinichi
    Shimizu, Tsuneo
    Furuya, Koro
    Uchida, Mikito
    Takeuchi, Nobuyasu
    Nakano, Shin
    Koizumi, Hidehito
    Kobayashi, Chikashi
    Fukasawa, Isao
    Takahashi, Teruo
    Kuroda, Katsuhiro
    Nishiyama, Yoshihisa
    Yoshioka, Hideyuki
    Horikoshi, Toru
    JOURNAL OF NEUROSURGERY, 2013, 118 (01) : 121 - 130
  • [12] Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial
    Sakuma, Masashi
    Toyoda, Shigeru
    Arikawa, Takuo
    Koyabu, Yota
    Kato, Toru
    Adachi, Taichi
    Suwa, Hideaki
    Narita, Jun-ichi
    Anraku, Koetsu
    Ishimura, Kimihiko
    Yamauchi, Fumitake
    Sato, Yasunori
    Inoue, Teruo
    PLOS ONE, 2022, 17 (01):
  • [13] A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation - A preliminary report with 6-month follow-up
    Gruessner, RWG
    Sutherland, DER
    Parr, E
    Humar, A
    Gruessner, AC
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1663 - 1664
  • [14] Levetiracetam in the prophylaxis of migraine with aura: A 6-month open-label study
    Brighina, Filippo
    Palermo, Antonio
    Aloisio, Antonina
    Francolini, Margherita
    Giglia, Giuseppe
    Fierro, Brigida
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (06) : 338 - 342
  • [15] A 6-month, open-label study of memantine in patients with frontotemporal dementia
    Diehl-Schmid, Janine
    Foerstl, Hans
    Perneczky, Robert
    Pohl, Corina
    Kurz, Alexander
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (07) : 754 - 759
  • [16] Methotrexate in Early Chikungunya Arthritis: A 6 Month Randomized Controlled Open-label Trial
    Adarsh, M. B.
    Sharma, Shefali K.
    Dwivedi, Preksha
    Singh, Mini P.
    Dhir, Varun
    Jain, Sanjay
    CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (04) : 319 - 323
  • [17] Evaluating the Safety and Efficacy of Telemedicine Physician Assessments on a Mobile Stroke Unit: Protocol for a Prospective Open-Label Blinded End-Point Randomized Controlled Trial
    Yogendrakumar, Vignan
    Balabanski, Anna H.
    Johns, Hannah
    Churilov, Leonid
    Parsons, Nicola K.
    Beharry, James
    Weir, Louise
    Yassi, Nawaf
    Zhao, Henry
    Warwick, Alex
    Coote, Skye
    Langenberg, Francesca
    Branagan, Leigh
    Siddiqi, Wasseem
    Bivard, Andrew
    Campbell, Bruce C. V.
    Donnan, Geoffrey A.
    Davis, Stephen M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (21):
  • [18] Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial
    Romeo Villadoniga, Stephanie
    Rodriguez Garcia, Elena
    Sagastagoia Epelde, Olatz
    Alvarez Diaz, M. Dolores
    Domingo Pedrol, Joan Caries
    JOURNAL OF OPHTHALMOLOGY, 2018, 2018
  • [19] Striving for Euthyroidism in Radioiodine Therapy of Graves' Disease: A 12-Year Prospective, Randomized, Open-Label Blinded End Point Study
    Chen, Dan Yun
    Schneider, Peter F.
    Zhang, Xiang Song
    He, Zhi Min
    Jing, Jin
    Chen, Tang Hua
    THYROID, 2011, 21 (06) : 647 - 654
  • [20] Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With SchizophreniaAn Open-Label Extension Study of a Randomized Clinical Trial
    Correll, Christoph U.
    Johnston, Karen
    Turkoz, Ibrahim
    Gray, Jason
    Sun, Liping
    Doring, Monica
    Sajatovic, Martha
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421495
12345